MedTrace Logo

Thrombin Generation Values and Percutaneous Coronary Intervention Results.

NCT03391622 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 128

Last updated 2022-11-08

No results posted yet for this study

Summary

Cardiovascular diseases are the most common cause of death in the western world. Myocardial infarction pathogenesis usually involves the development of an atherosclerotic plaque and thrombus.

Past research has shown a correlation between thrombin generation values and ischemic heart disease, however, to our knowledge no investigation has been done into the correlation of thrombin generation and cardiac catheterization results in ischemic heart disease patients.

In the current research the investigator will investigate the correlation of thrombin generation values using calibrated automated thrombogram and cardiac catheterization results in active ischemic heart disease patients.

Conditions

  • Coagulation Disorder
  • Ischemic Heart Disease
  • Artery Coronary Stenosis

Interventions

DEVICE

Calibrated Automated Thrombogram

blood samples will be collected . Thrombin generation in platelet-poor plasma will be measured by means of the Calibrated Automated Thrombogram (CAT).

Sponsors & Collaborators

  • HaEmek Medical Center, Israel

    lead OTHER

Principal Investigators

  • Boaz Elad, MD · HaEmek Medical Center, Israel

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-04-01
Primary Completion
2020-08-30
Completion
2020-08-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03391622 on ClinicalTrials.gov